Non-interventional PASS to Evaluate Safety of Kineret in Treatment of CAPS in Routine Clinical Care With Regard to Serious Infections, Malignancies, Injection Site Reactions, Allergic Reactions, Medication Errors Including Re-use of Syringe
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 29 Aug 2017
At a glance
- Drugs Anakinra (Primary)
- Indications Cryopyrin-associated periodic syndromes
- Focus Adverse reactions
- Sponsors Swedish Orphan Biovitrum
- 23 Aug 2017 Planned End Date changed from 1 Dec 2019 to 1 Apr 2020.
- 23 Aug 2017 Planned primary completion date changed from 1 Dec 2019 to 1 Apr 2020.
- 23 Aug 2017 Status changed from recruiting to active, no longer recruiting.